They want the British developed vaccine.
International and Indian media reported that in some hospitals, frontline health workers have refused to take Covaxin, demanding access to Covishield instead.
The reason? India has not fully approved Covaxin: India’s Covid-19 vaccination: Do you feel lucky?
Covishield, the AstraZeneca vaccine manufactured by the Serum Institute of costs the Indian govt Rs200 (US$2.7). Covaxin the the vaccine indigenously developed by Bharat Biotech costs Rs206 a dose: 3% more.
And don’t forget, India has not fully approved Covaxin– India’s Covid-19 vaccination: Do you feel lucky?
Goldman Sachs now expects US GDP to expand 6.6% this year, with the unemployment rate ticking down to 4.5″. No wonder markets are flying.
Beat that Loser Trump. Sleepy Joe trumps Loser Trump
